R&D The Autumn Budget: What it means for UK life sciences deVere and Inventus comment on the UK Autumn Budget and what it means for life sciences in the country.
Market Access Money vs mindset: How the NHS can make the most of extra inv... It was the day we’d all been waiting for. Rachel Reeves’ Autumn Budget felt like it had been on the horizon for a while.
News NHS under scrutiny amid worst-ever performance in cancer and... The performance of the NHS has come under the spotlight once again, following figures showing worst-ever performances against waiting times targets for cancer treatment and in A&E.
News Tax breaks could nurture UK’s cell and gene therapy manufact... Tax breaks for R&D and innovative manufacturing could be part of life sciences strategy.
News NHS set to lose out to Brexit in budget Brexit bill and debt levels make spending spree unlikely, says Chancellor
News ESMO26: Sac-TMT delivers the goods in PD-L1-negative NSCLC Kelun and MSD's TROP2-directed ADC, sac-TMT, reduced the risk of disease progression or death by 51% when used first-line in PD-L1-negative NSCLC.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
